Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FED × Midazolam × Other hematologic neoplasm × Clear all

Phase

Status

Sponsor Class

INDUSTRY 4 FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Anxiety Disorders 1

Interventions

Clofarabine 2 talabostat 1 Topotecan 1 Tablets 1 Rituximab 1 PT-100 dipeptide 1 Mitoxantrone 1 Midazolam 1 Ketamine 1 Exercise 1 Etoposide 1 Dosage Forms 1 Azacitidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03043430 2023-04-25

Intranasal Ketamine for Anxiolysis in Pediatric Emergency Department Patients

Brooke Army Medical Center

Phase 4 Terminated

LymphoidOther hematologic neoplasm

Anxiety Disorders, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡